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Objectives: to identify the degree of knowledge of people with hypertension concerning the 
disease and to verify the factors associated with the non-adherence to anti-hypertensive drug 
therapy. Method: Cross sectional study, involving 422 people. Data collection took place at 
their homes, between December 2011 and March 2012, through interviews using the following 
instruments: Medication Adherence Questionnaire (MAQ-Q), Medication Regimen Complexity 
Index (MRCI) and a guide with questions related to sociodemographic profile, satisfaction with 
healthcare service and knowledge about the disease. Results: 42.6% did not adhere to the drug 
therapy and 17.7% had poor knowledge about the disease. Factors associated with the non-
adherence were: complex drug therapy, poor knowledge about the disease and dissatisfaction 
with the healthcare service. Conclusion: The findings reinforce that the complex drug therapy 
prescriptions, little knowledge about the disease and dissatisfaction with the healthcare service 
have influence on the process of non-adherence to anti-hypertensive drug therapy.
Descriptors: Hypertension; Medication Adherence; Risk Factors; Health Knowledge, Attitudes, 
Practice; Nursing.
Knowledge about hypertension and factors associated
with the non-adherence to drug therapy1
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Introduction
Systemic Arterial Hypertension (SAH), when 
not controlled, is still being a significant medical 
and social problem in developed and developing 
countries. Even knowing the efficacy, effectiveness 
and efficiency of many available preventive and 
control measures, the negative effects caused by 
the disease will probably continue for decades, 
representing one of the biggest social and health 
related challenges(1).
One of the main causes of the negative effects 
caused by SAH is the non-adherence to hypertensive 
treatment, as well as the late diagnosis and the prolonged 
asymptomatic course of the disease, which resulted in 
the development of studies in the area(2-5). Estimates 
point out that the degree of the non-adherence to the 
treatments of Chronic Diseases (CD) worldwide ranges 
from 25% to 50%(6). 
The non-adherence to the drug therapy in cases of 
CD, usually verified through the Morisky-Green-Levine 
test(7), is considered a complex and multi determined 
event associated with low socioeconomic levels, complex 
prescription regimens and dissatisfaction with the 
healthcare service, which are factors that prevail among 
the population with SAH(4,8-11).
Another explanation for the high rate of non-
adherence is that many patients do not understand the 
disease and the drug therapy. The asymptomatic course 
of the SAH contributes to this lack of understanding 
and, as a result, many people believe that the disease 
is intermittent and can be treated exclusively with 
non-medication therapies, such as stress relief or 
homemade medication(10).
The relationship between the non-adherence 
to the SAH treatment and the patient’s knowledge 
about the disease and therapeutic regimen has been 
reported(4-6,10). However, this relationship requires 
further evidence(5,12). Moreover, in order for the 
healthcare professionals to act more effectively, by 
proposing and implementing actions that meet the 
real needs of this population, it is necessary to identify 
the patients who do not adhere to the treatment 
and their characteristics, and the reasons why 
this occurs.
Based on the above, the present study was aimed 
at: identifying the degree of knowledge of people with 
arterial hypertension about the disease and verifying the 
factors associated with the non-adherence to the anti-
hypertensive drug therapy.
Method
Cross sectional, descriptive study, involving people 
with SAH, undergoing outpatient care treatment at the 
Primary Healthcare Service in a city located in the South 
region of Brazil, which had 25 primary healthcare units 
(UBS) and 65 teams of the Family Health Strategy (ESF) 
at the time of data collection. For the purposes of this 
research, the area covering the 23UBS located within 
the perimeter of the city was used by convenience.
The size of the sample was calculated based on the 
total of people with SAH registered in the city (40,073). 
It was assumed that 50% of people could have the 
characteristic of interest (non-adherence)(6), estimation 
error of 5%, and a confidence interval of 95%. 10% 
more was added for possible losses, resulting in a 
stratified and randomly selected sample of 422 people, 
with a distribution that was proportional to the total 
number of people with SAH registered in each UBS of 
the urban area.
As inclusion criteria, the following was considered: 
to be 18 years old or more and to have started drug 
therapy for at least one year, since the interruption 
of antihypertensive treatment occurs more often in 
the first months after it starts, with 11% to 22% of 
the cases occurring in the first year(6). Seventeen 
people were excluded, including two women who used 
antihypertensive drugs only during pregnancy and 15 
people with a psychiatric diagnosis of acute mental 
disorder because they tend not to adhere to the therapy 
due to the own nature of the disease, besides the fact 
that many of them relied on other people to properly 
take the continuous use medication.
For data collection, a list divided by UBS was firstly 
obtained from the City Health Council with records of the 
people with SAH, who were given a number. Through an 
electronic draw, those people who would be interviewed 
were selected. If the selected person did not meet the 
inclusion criteria or if they refused to participate in the 
research, the next person on the list was automatically 
invited to participate in the study, and this was repeated 
for up to three times.
After obtaining the addresses and telephone 
numbers of the people selected, which took place 
at the UBS, the data collection was conducted and 
happened during the period from December 2011 and 
March 2012, through home visits with the use of a 
semi-structured guide composed of questions related 
to the sociodemographic profile, health monitoring and 
knowledge about the disease, which was completed by 
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the researcher. The economic level was defined on the 
basis of the Economic Classification Criteria of Brazil 
(Brazilian Association of Research Companies – ABEP) 
which is based on the educational level and consumer 
goods and is used to estimate the spending power of 
people and families. In this study, the eight possible 
levels (A1-A2-B1-B2-C1-C2-D-E) were grouped into two 
levels A/B and C/D/E.
Procedures and data analysis
The dependent variable was the non-adherence 
to the hypertensive drug therapy. An instrument of 
indirect evaluation was used for its measurement, the 
Medication Non-Adherence Questionnaire (MAQ-Q) of 
the Qualiaids team, developed to address the act (if the 
person takes their medication and how much they take), 
the process (how they take the medication), and the 
result of adherence (in this case, if the blood pressure 
is controlled)(13).
The developed and validated instrument(13) takes 
into account the statement of the participant as a source 
of information and has three questions, the two first 
being based on the last seven days, 1) On which days 
of the week you did not or you did take more than at 
least one pill of this medication?; 2) On these days, how 
many pills  you did  not take, or took more than it was 
prescribed?; 3) How was your blood pressure when you 
last measured it?. It is important to note that there was 
no time restriction for this last question.
The answers resulted in a combined measurement, 
in which only the people who reported to have taken 
between 80% and 120% of the prescribed dosages 
were considered adherent. These values are obtained by 
multiplying the number of pills taken by the number of 
times, and dividing it by the number of pills prescribed 
multiplied by the number of times. Finally, the result is 
multiplied by one hundred.
Adherence was also conditioned to the adequate 
intake, that is, without “breaks” (not taking any 
medication for one day), “change of time” (taking the 
correct dose, but at wrong times), “change of dose” 
(increasing or reducing the amount of the medication 
or between medications), “erratic intake” (not taking 
the medications in various days and times), “half 
adherence” (taking one medication correctly and 
another incorrectly), “partial interruption” (stopping 
taking one or more of their medications), “interruption” 
(not taking any dose of all medications in the last seven 
days) and to the report that the BP was normal in the 
last measurement (clinical outcome).
It was chosen to use the MRCI because it is a 
comprehensive instrument, which includes three different 
dimensions of the construct related to the adherence 
(dose intake, behavior related to the medication and 
clinical outcome), provides the same effectiveness as 
the concomitant use of other instruments and enables 
easier and quicker application(13).
Independent variables
The knowledge about the disease was verified 
using 10 questions, with dichotomous answers (yes/
no)(8). Through the instrument, people who answers 
all the questions correctly receive a score 10 (100%) 
and those who answer them all incorrectly receive a 
zero. Similarly to another study(10), the knowledge was 
considered satisfactory for those with scores equal or 
above seven (70%) and dissatisfactory for the others in 
this investigation.
As for the complexity of the drug therapy, this was 
assessed through the Medication Regimen Complexity 
Index (MRCI), a valid instrument(14) in which the final 
score is obtained by adding the scores of the three 
sections – A, B and C – and the higher the score, the 
more complex the drug therapy(14). The first section has 
information about dosage ways; the second, about the 
frequency of doses; and the third, additional information 
such as specific times, breaking or crushing the pill and 
concomitant use with food.
The  satisfaction of the user with the healthcare 
service was estimated based on eight questions, two 
being related to the structure and access to the service, 
three to the assistance, treatment and care provided by 
the professionals at the UBS, two to the satisfaction with 
the treatment and with the doctor, and one to the general 
satisfaction. The score scale of answers is the Likert 
type with four possible alternatives, one representing 
maximum satisfaction and four, total dissatisfaction. 
After obtaining the average scores, the median divided 
the sample into groups of “more satisfied” and “less 
satisfied”, as used in another study(4).
The information was entered into an Excel for 
Windows 2007® spreadsheet and later statistically 
analyzed through the software Statistical Analysis 
System – SAS®. The variables of interest were 
dichotomized. In the logistic regression of the type 
Stepwise Backward Elimination, all the variables were 
inserted and after the application of the tests, only the 
variables with statistical significance with p<0.20 were 
kept in the adjusted model. In order to verify the extent 
of the association, the Relative Risk (RR) of the variables 
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was calculated, which remained in the final model of the 
logistic regression at 5% significance level.
The study complied with the guidelines of 
Resolution 196/96 of the National Health Council, and its 
project was approved by the Permanent Research Ethic 
Committee involving human beings of the Universidade 
Estadual de Maringá (Opinion 631/2011).
Table 1 - Univariate analysis of the association between the non-adherence to drug therapy and bio-socioeconomic 
and health monitoring related factors concerning hypertensive patients. Maringa, PR, Brazil, 2012
*Based on the  Economic Classification Criteria of Brazil (Brazilian Association of Research Companies – ABEP) 
†p-significant value in the logistic regression model Stepwise Backward Elimination
Variables
Adherence
Total
pNo Yes
n % n % n %
Gender 0.14
Female 98 23.22 153 36.26 251
Male 82 19.43 89 21.09 171
Age 0.64
<60 years 67 15.99 87 20.76 154
≥60 years 111 26.49 154 36.75 265
Race 0.33
Caucasian 115 27.25 181 42.89 296
Non Caucasian 65 15.41 61 14.45 126
Marital status 0.64
Married 117 27.73 174 41.23 291
Single 63 14.93 68 16.12 131
Level of education 0.52
≤ 08 years 126 29.86 142 33.65 268
> 08 years 54 12.79 100 23.70 154
Economic level* 0.91
A/B 47 11.13 72 17.06 119
C/D/E 133 31.52 170 40.29 303
Time since diagnosis 0.64
≤10 years 102 24.17 135 31.99 237
>10 years 78 18.49 107 25.35 185
Comorbidities 0.40
Yes 108 25.60 150 35.54 258
No 72 17.06 92 21.80 164
Medication Regimen Complexity Index 0.02†
Low 91 21.56 155 36.73 246
High 89 21.09 87 20.62 176
Satisfaction with healthcare service 0.00†
Satisfied 70 17.81 156 39.70 226
Dissatisfied 98 24.94 69 17.55 167
Satisfactory knowledge 0.00†
Yes 123 29.14 224 53.09 347 82.23
No 57 13.51 18 4.26 75 17.77
Results
Based on the combined measurement of the MRCI, 
it was found that 180 (42.65%) people were considered 
to be non-adherent to the antihypertensive drug therapy 
(Table 1).
Regarding the characteristics, the majority of the 
studied people were female (59.48%), elderly (63.25%), 
Caucasian (70.14), married (68.96%), with low level of 
education (63.51%), low family income (71.81%), less 
than 10 years from the SAH diagnosis (56.16%), but who 
already presented comorbidities (61.14%). However, 
none of these characteristics had significant association 
with the outcome of interest (p<0.05) (Table 1).
In turn, the people with SAH who had little 
knowledge about their disease (p=0.00), complex drug 
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Table 2 - Distribution of people with arterial hypertension who adhered or not to the hypertensive drug therapy 
according to the positive attitudes in relation to the knowledge about the disease, Maringa, PR, Brazil, 2012
*p-significant value in the Pearson’s Chi square test
therapy (p=0.02) and dissatisfaction with the healthcare 
service (p=0.00) were respectively 2.1 (IC: 1.7-2.7), 
1.4 (IC: 1.1-1.7) e 1.9 (IC: 1.51-2.39) times more likely 
not to adhere to the drug therapy.
The data in Table 2 show that most people with SAH 
had satisfactory knowledge about the disease, since 
eight questions had accuracy percentage over 70.0%. 
Question in relation to the
knowledge about the disease
Adherent
(242)
Non-adherent 
(180) p Relative risk
Confidence 
Interval
n % n %
Is high blood pressure a lifelong disease? 192 79.33 141 78.33 0.80 - -
Most times, do people with high blood pressure feel anything different? 144 59.50 89 49.44 0.03* 1.3 1.01-1.57
Is the pressure high when it is ≥ 14/9? 197 81.40 137 76.11 0.18 - -
Can high blood pressure cause heart, brain and kidney problems? 212 87.60 157 87.22 0.90 - -
Is the treatment for high blood pressure a lifelong one? 219 90.49 137 76.11 0.00* 1.7 1.31-2.19
Can high blood pressure be treated without the use of medication? 96 39.66 51 28.33 0.01* 1.4 1.06-1.73
Do regular physical exercises help control high blood pressure? 219 90.49 143 79.44 0.00* 1.6 1.19-2.05
Does losing weight help control high blood pressure in obese people? 230 95.04 159 88.33 0.01* 1.6 1.11-2.19
Does reducing salt intake help control high blood pressure? 241 99.58 173 96.11 0.00* 2.1 1.20-3.66
Does reducing stress help control high blood pressure? 237 97.93 166 92.22 0.00* 1.8 1.19-2.69
However, the low rate of accuracy in relation to two 
questions can be noted: only 59.50% of the adherent 
participants and 49.44% of the non-adherent ones were 
aware that, in most cases, the SAH is a silent disease, 
and 39.66% of the adherent participants and 28.33% of 
the non-adherent ones were aware that the disease can 
also be treated without the use of medications.
Of the 10 questions applied to assess the knowledge 
of the participants, seven had statistically significant 
association with the non-adherence to drug therapy. 
The calculation of the RR showed that, in general, 
the little knowledge about the SAH and its treatment 
increases 1.3 to 2.1 times the chance that a person 
with SAH does not properly adhere to the proposed 
drug therapy.
Discussion
The predominance of people who did not adhere 
to the drug therapy identified in this study (42.65%) 
is lower than that found in a research conducted in 
another Brazilian city, also located in the South region, 
which showed the predominance of 53.1% of people 
who did not adhere to it, using the same instrument 
(MRCI)(4). This difference of more than 10% could be 
a consequence of the distinct characteristics of the 
samples. In the present study, for example, there was a 
higher number of married people, with more than eight 
years of education and who belonged to the A and B 
economic levels, which positively affects the adherence 
process(2,9). However, the predominance of people who 
did not adhere to the drug therapy in others studies that 
used the Morisky-Green-Levine and Batalla tests(7,15) and 
manual count of pills(16) is lower than that found in this 
study, approximately 30%(7,15-16).
Biological and socioeconomic characteristics such 
as gender, age, marital status, level of education, 
economic level and race, were described in other studies 
as predictors of adherence/non-adherence to the SAH 
treatment(17-18). However, in the present investigation, 
none of these variables were statistically significant to 
the outcome of interest. This might be partially explained 
by the difference of methods used to measure the non-
adherence to the therapy.
One factor that has been studied in conjunction to 
the process of adherence/non-adherence to the drug 
therapy is the complexity of the therapeutic regimen. In 
the present investigation, the high complexity of the drug 
therapy can be observed in 41.71% of the participants 
and it is more predominant and significant among 
those who did not adhere. However, the existence of a 
relationship between the complexity of the therapeutic 
regimen and the adherence to the drug therapy is not 
always so direct or easily noted.
In any event, similarly to the results of this study, 
a research carried out in a city located in the Southeast 
region of Brazil, for example, involving 120 elderly people 
with SAH, found a strong correlation between a higher 
complexity of the drug therapy and a low adherence to 
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the treatment(11), while  a randomized study conducted 
in Japan, which involved 207 people with SAH, showed 
that there was no significant difference in the adherence 
to the antihypertensive drug therapy between the group 
that took only one pill and the control group, which took 
two of them(19).
However, even without a consensus in the literature, 
the simplification of the therapeutic regimen has been 
shown to have an impact on the adherence to drug 
therapy. A literature review study showed that the use of 
medications combined in a single daily dose, rather than 
the free combination of the medication taken in different 
times, was shown to be associated with a significant 
increase in the treatment adherence(17).
However, in relation to people’s knowledge about 
the disease, the data available seem more consolidated, 
showing that the lack of knowledge, the beliefs and 
myths that patients have about their disease, the 
demotivation to control it, the inability to associate their 
behavior with the management of adverse situations 
and the low expectations of the result of the treatment 
negatively affect the adherence(3).
In the present investigation, it was observed that 
most people with SAH had satisfactory knowledge about 
the disease, and only two questions had an accuracy 
percentage below 70.0%, which is consistent to other 
Brazilian studies(8,10). The low accuracy rate, when it 
occurs, may be associated with the degree of knowledge of 
the patients about the disease or with other factors, such 
as the acceptance of the CD, the motivation to apprehend 
the information and even the level of education(10).
A research conducted in Sao Paulo (SP) with 511 
patients monitored by a Hypertension League showed 
a high degree of knowledge about the alternative 
ways to treat the disease, considering that more 
than 80% of them recognized the benefits of quitting 
smoking, reducing weight, practicing physical exercise 
and reducing alcohol intake, which positively affected 
adherence to treatment(20). Similarly, a study undertaken 
in Pakistan with 477 people with SAH showed that 
those with adequate control of blood pressure 
levels were exactly those who had more knowledge 
about the disease(21).
The fact that people with SAH had a satisfactory 
knowledge about the disease is very positive and at 
least an indication that these people are having more 
access to information, either by their own initiative, or 
due to a greater dissemination in the vehicles of mass 
communication, or even due to a better performance 
of healthcare professionals, in particular the ESF 
teams. Thus, it is possible to conclude that this level 
of assistance has been reaching its purposes, given 
that one of the foundations of the SAH treatment in 
the primary healthcare is health education, focused 
on lifestyle change, adherence to drug therapy when 
prescribed and prevention of illnesses resulting from 
lack of control of the disease.
Based on the facts above exposed, it can be noted 
that the higher the degree of patients’ knowledge about 
the disease, the greater the self-care and the adherence 
to treatment. However, the problem of adherence is 
more complex, because the access to information about 
the SAH does not necessarily imply greater adherence 
to the control measures(1). From this perspective, a 
randomized study developed in Spain with 996 people 
with SAH, showed that educational interventions did not 
have a significant impact on the patients’ adherence to 
the medication(5).
This is because there is inconsistency between 
having information about the disease and adhering to 
drug therapy and controlling the BP. Thus, there is an 
essential difference between knowledge and practice, 
which means that although knowing what needs to be 
done, patients do not act according to such knowledge, 
because while the knowledge is rational, the adherence 
involves a multifactorial process affected by emotional, 
social, biological and cultural factors(1).
In this sense, it cannot be denied that, by increasing 
the coverage of the primary healthcare services, provided 
through the implementation of the ESF, the access of the 
population to primary healthcare improved, allowing, 
among other advancements, the creation of bonds 
between the users and the ESF teams, which tends to 
support the systematic monitoring and the development 
of health promotion and disease prevention activities(22). 
However, it can be noted that there should not be only 
the simple transmission of information on the part of 
the healthcare teams, especially the nurses, to avoid the 
opening of a gap between the guidance provided by the 
professional and its effective applicability.
Therefore, one of the main duties of nurses when 
providing care to patients with SAH and their families 
in the primary healthcare is to seek prevention of 
illnesses and promoting health. Thus, during the nursing 
appointments and the Hiperdia groups, professionals 
should perform health education actions, encouraging 
the supported self-care, so that people, families and 
groups can develop skills that enable them to act 
consciously in relation to changeable risk factors, among 
them the adherence to drug therapy(2).
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Taking this into account, the quality of the work 
performed by  nurses in the healthcare services is critical 
because providing innovative care to groups with CD and 
their families at a UBS is essential to raise awareness 
among them, so that together – patient, family and 
professionals – they develop treatment guidelines(23).
For the joint planning of the care, aimed at the 
adherence to drug therapy and control of blood pressure, 
it is essential the presence of the patient in the UBS. 
The dialogue with the professionals brings individual 
motivation and this, in turn, guides certain attitudes 
that contribute for the reduction of the BP. Regular 
meetings/appointments provide better monitoring of the 
blood pressure levels, as well as the opportunity to have 
more access to information, and can serve as a basis for 
compliance with the guidelines related to the drug and 
alternative therapies(7).
From this perspective, the access to health care 
has been pointed out as relevant to the adherence to 
hypertensive treatment. Therefore, the current health 
policies, the easy access of patients to healthcare services 
and the quality of the work developed by professionals 
and managers directly affect the adherence process(17). 
Thus, current researches confirm the strong correlation 
between the satisfaction with the healthcare services 
and the adherence/non-adherence issue(4,11).
Despite some methodological limitations, such 
as the fact that the study participants were selected 
from those registered in the Hiperdia Program and who 
performed drug therapy for at least one year, which 
resulted in a sample mainly composed of women and 
elderly people, and also the different possible methods 
to identify the non-adherence to drug therapy, which 
makes it hard to compare the results found, it can be 
stated that the predominance of people who do not 
adhere to the SAH treatment in primary healthcare in 
the locus of the study is high and does not differ much 
from what has been found in other Brazilian cities. These 
issues, therefore, are a challenge for the healthcare 
sector in cities with different population sizes and located 
in the various regions of the country.
Conclusion
The results showed that 42.6% of the people with 
SAH studied were considered to be non-adherent to the 
drug therapy and that, although only 17.7% had little 
knowledge about the disease, this is a factor associated 
to the non-adherence to the drug therapy. Other factors 
associated with the non-adherence to the treatment 
were: complex drug therapy and dissatisfaction with the 
healthcare service.
These findings reinforce the need for the healthcare 
professionals working in the primary healthcare, 
particularly nurses – professionals who regularly 
deal with people with SAH, the reason why the non-
adherence issue should be continuously studied by 
nursing professionals – to work towards simplifying 
the therapeutic regimen, to create a greater bonding 
with the population and, from that, develop activities 
to promote health and prevent illnesses, with transfer 
of information and awareness of the population with 
SAH under their care about the importance of properly 
adhere to antihypertensive treatment agreed with the 
healthcare provider.
References
1. Silva LOL, Soares MM, Oliveira MA, Rodrigues SM, 
Machado CJ, Dias CA. “Tô sentindo nada”: percepções 
de pacientes idosos sobre o tratamento da hipertensão 
arterial sistêmica. Physis: Rev Saúde Coletiva. 
2013;23(1):227-42.
2. Reiners AAO, Nogueira MS. Raising hypertensive 
patients’ consciousness about treatment compliance. 
Rev. Latino-Am. Enfermagem. 2009;17(1):59-65.
3. Gusmão JL, Ginani GF, Silva GV, Ortega KC, Mion-
Junior D. Adesão ao tratamento em hipertensão arterial 
sistólica isolada. Rev Bras Hipertens. 2009;16(1):38-43.
4. Santa-Helena ET, Nemes MIB, Eluf-Neto J. Fatores 
associados à não adesão ao tratamento com anti-
hipertensivos em pessoas atendidas em unidades 
de saúde da família. Cad Saude Pública. 2010; 
26(12):2389-98.
5. Guirado EA, Ribera EP, Huergo VP, Borras JM. 
Knowledge and adherence to antihypertensive therapy 
in primary care: results of a randomized trial. Gac Sanit. 
2011;25(1):62-7.
6. Morgado M, Rolo S, Macedo AF, Pereira L, Castelo-
Branco M. Predictors of uncontrolled hypertension and 
antihypertensive medication nonadherence. J Cardiovasc 
Dis Res. 2010;(4):196-202.
7. Dosse C, Cesarino, CB, Martin JFV, Castedo MCA. 
Factors associated to patients’ non-compliance with 
hypertension treatment. Rev. Latino-Am. Enfermagem. 
2009;17(2):201-6.
8. Strelec MAAM, Pierin AMG, Mion-Junior D. A influência 
do conhecimento sobre a doença e a atitude frente 
à tomada dos remédios no controle da hipertensão 
arterial. Arq Bras Cardiol. 2003;81(4):43-8.
498
www.eerp.usp.br/rlae
Rev. Latino-Am. Enfermagem 2014 May-June;22(3):491-8.
Received: Aug 22nd 2013
Accepted: Mar. 13th 2014
9. Sociedade Brasileira de Cardiologia, Sociedade 
Brasileira de Hipertensão, Sociedade Brasileira de 
Nefrologia. VI Diretrizes Brasileiras de Hipertensão. Arq 
Bras Cardiol. 2010;95 Supl1:1-51.
10. Pucci N, Pereira MR, Vinholes DB, Pucci P, Campos 
ND. Conhecimento sobre Hipertensão Arterial Sistêmica 
e Adesão ao Tratamento Anti-Hipertensivo em Idosos. 
Rev Bras Cardiol. 2012;25(4):322-9.
11. Obreli-Neto PR, Prado MF, Vieira JC, Fachini FC, Pelloso 
SM, Marcon SS, Cuman RKN. Fatores interferentes na 
taxa de adesão à farmacoterapia em idosos atendidos 
na rede pública de saúde do Município de Salto Grande. 
Rev Cienc Farm Basica Apl. 2010;31(3):229-33.
12. Osamor PE, Owumi BE. Factors Associated with 
tratament compliance in hypertension in Southwest 
Nigeria. J Health Popul Nutr. 2011; 29(6):619–28.
13. Santa-Helena ET, Nemes MIB, Eluf-Neto J. 
Desenvolvimento e validação de questionário 
multidimensional para medir não adesão ao 
tratamento com medicamentos. Rev Saude Pública. 
2008; 42(4):764-7.
14. Melchiors AC, Correr CJ, Llimos FF. Tradução 
e Validação para o Português do Medication 
Regimen Complexity Index. Arq Bras Cardiol. 2007; 
89(4):210-8.
15. Carvalho ALM, Leopoldino RWD, Silva JEG, Cunha 
CP. Adesão ao tratamento medicamentoso em usuários 
cadastrados no Programa Hiperdia no município 
de Teresina (PI). Ciênc Saúde Coletiva. 2012; 
17(7):1885-92.
16. Garcia JE, Claros NM, Ruiz AL, Gurrea DFB. 
Cumplimiento farmacológico en el tratamiento de la 
hipertensión arterial: Revisión de los estudios publicados 
entre los años 1975 y 2011. Semergen: Medic Famil. 
2012;38(5):292-300.
17. Gupta AK, Arshad S, Poulter NR. Compliance, 
Safety, and Effectiveness of Fixed-Dose Combinations of 
Antihypertensive Agents: A Meta-Analysis. Hypertension. 
2010;55(2):399-407.
18. Veras RFS, Oliveira JS. Aspectos sócio-demográficos 
que influenciam na adesão ao tratamento anti-
hipertensivo. Rev RENE. 2009;10(3):132-8.
19. Matsumura K, Arima H, Tominaga M, Oshtsubo T, 
Sasaguri T, Fujii K, et al. Does a combination pill of 
antihypertensive drugs improve medication adherence 
in Japanese? A randomized controlled trial. Circ J. 
2012;76(6):1415-22.
20. Serafim TS, Jesus ES, Pierin AMG. Influence 
of knowledge on healthy lifestyle in the control of 
hypertensive. Acta Paul Enferm. 2010;23(5):658-64.
21. Almas A, Godil SS, Lalani S, Samani ZA, Khan 
AH. Good Knowledge about hypertension is linked 
to better control of hypertension a multicenter cross 
sectional study in Karachi, Pakistan. BMC Res Notes. 
2012;5:579.
22. Costa JMBS, Silva MRF, Carvalho EF. Avaliação da 
implantação da atenção à hipertensão arterial pelas 
equipes de Saúde da Família do município do Recife (PE, 
Brasil). Cienc Saúde Coletiva. 2011;16(2):623-33.
23. Elsen I, Souza AIJ, Prospero ENS, Barcellos WBE. O 
cuidado profissional às famílias que vivenciam a doença 
crônica em seu cotidiano. Cienc Cuid Saúde. 2009;8 
Supl:11-22.
